Research Topics

Genomes and Genes

Species

Laura H Tang

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. Tang L, Klimstra D. Conundrums and Caveats in Neuroendocrine Tumors of the Pancreas. Surg Pathol Clin. 2011;4:589-624 pubmed publisher
    ..The diagnosis of a Pan-NET requires analysis of all available clinical and radiographic information and pathologic characteristics of the tumor, and it is crucial to understand the clinical impact of the pathologic interpretation. ..
  2. Corrias G, Monti S, Horvat N, Tang L, Basturk O, Saba L, et al. Imaging features of malignant abdominal neuroendocrine tumors with rare presentation. Clin Imaging. 2018;51:59-64 pubmed publisher
    ..The workup of the abnormalities was performed with CT, PET or MRI. The diagnosis of NETs is challenging and generally based on clinical manifestations, blood biochemical tests, imaging techniques, and pathology. ..
  3. Tang L, Gonen M, Hedvat C, Modlin I, Klimstra D. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods. Am J Surg Pathol. 2012;36:1761-70 pubmed publisher
    ..Consequently, determination of therapeutic strategies should be guided by an amalgamation of clinicopathologic characteristics, including but not limited to the Ki67 index. ..
  4. Galleberg R, Knigge U, Tiensuu Janson E, Vestermark L, Haugvik S, Ladekarl M, et al. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas. Eur J Surg Oncol. 2017;43:1682-1689 pubmed publisher
    ..Our findings indicate a possible role for surgical treatment of liver metastases in the management of this patient population. ..

Locale

Detail Information

Publications4

  1. Tang L, Klimstra D. Conundrums and Caveats in Neuroendocrine Tumors of the Pancreas. Surg Pathol Clin. 2011;4:589-624 pubmed publisher
    ..The diagnosis of a Pan-NET requires analysis of all available clinical and radiographic information and pathologic characteristics of the tumor, and it is crucial to understand the clinical impact of the pathologic interpretation. ..
  2. Corrias G, Monti S, Horvat N, Tang L, Basturk O, Saba L, et al. Imaging features of malignant abdominal neuroendocrine tumors with rare presentation. Clin Imaging. 2018;51:59-64 pubmed publisher
    ..The workup of the abnormalities was performed with CT, PET or MRI. The diagnosis of NETs is challenging and generally based on clinical manifestations, blood biochemical tests, imaging techniques, and pathology. ..
  3. Tang L, Gonen M, Hedvat C, Modlin I, Klimstra D. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods. Am J Surg Pathol. 2012;36:1761-70 pubmed publisher
    ..Consequently, determination of therapeutic strategies should be guided by an amalgamation of clinicopathologic characteristics, including but not limited to the Ki67 index. ..
  4. Galleberg R, Knigge U, Tiensuu Janson E, Vestermark L, Haugvik S, Ladekarl M, et al. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas. Eur J Surg Oncol. 2017;43:1682-1689 pubmed publisher
    ..Our findings indicate a possible role for surgical treatment of liver metastases in the management of this patient population. ..